# COVID-19 Clinical Research Studies

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/covid-19-clinical-research-studies/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the clinical characteristics, epidemiology, immune response, and treatment of Coronavirus Disease 2019 (COVID-19), caused by the SARS-CoV-2 virus. It covers topics such as thrombosis, ACE2 receptor, cytokine storm, and the pandemic's impact on various populations. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t10041 |
| Works | 1,206 |

## Topic papers all

Showing 15 of 1206.

- [Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study](https://scholariq.org/papers/clinical-course-and-risk-factors-for-mortality-of-adult-inpatients-with-covid-19/)
- [A pneumonia outbreak associated with a new coronavirus of probable bat origin](https://scholariq.org/papers/a-pneumonia-outbreak-associated-with-a-new-coronavirus-of-probable-bat-origin/)
- [Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China](https://scholariq.org/papers/risk-factors-associated-with-acute-respiratory-distress-syndrome-and-death-in/)
- [Dexamethasone in Hospitalized Patients with Covid-19.](https://scholariq.org/papers/dexamethasone-in-hospitalized-patients-with-covid-19/)
- [Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro](https://scholariq.org/papers/remdesivir-and-chloroquine-effectively-inhibit-the-recently-emerged-novel/)
- [Factors associated with COVID-19-related death using OpenSAFELY](https://scholariq.org/papers/factors-associated-with-covid-19-related-death-using-opensafely/)
- [Endothelial cell infection and endotheliitis in COVID-19](https://scholariq.org/papers/endothelial-cell-infection-and-endotheliitis-in-covid-19/)
- [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges](https://scholariq.org/papers/severe-acute-respiratory-syndrome-coronavirus-2-sars-cov-2-and-coronavirus/)
- [Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy](https://scholariq.org/papers/baseline-characteristics-and-outcomes-of-1591-patients-infected-with-sars-cov-2/)
- [A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19](https://scholariq.org/papers/a-trial-of-lopinavir-ritonavir-in-adults-hospitalized-with-severe-covid-19/)
- [Post-acute COVID-19 syndrome](https://scholariq.org/papers/post-acute-covid-19-syndrome/)
- [Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China](https://scholariq.org/papers/dysregulation-of-immune-response-in-patients-with-coronavirus-2019-covid-19-in/)
- [Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK](https://scholariq.org/papers/safety-and-efficacy-of-the-chadox1-ncov-19-vaccine-azd1222-against-sars-cov-2-an/)
- [Persistent Symptoms in Patients After Acute COVID-19](https://scholariq.org/papers/persistent-symptoms-in-patients-after-acute-covid-19/)
- [Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China](https://scholariq.org/papers/cancer-patients-in-sars-cov-2-infection-a-nationwide-analysis-in-china/)

## Topic primary papers

Showing 15 of 546.

- [Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study](https://scholariq.org/papers/clinical-course-and-risk-factors-for-mortality-of-adult-inpatients-with-covid-19/)
- [Dexamethasone in Hospitalized Patients with Covid-19.](https://scholariq.org/papers/dexamethasone-in-hospitalized-patients-with-covid-19/)
- [Endothelial cell infection and endotheliitis in COVID-19](https://scholariq.org/papers/endothelial-cell-infection-and-endotheliitis-in-covid-19/)
- [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges](https://scholariq.org/papers/severe-acute-respiratory-syndrome-coronavirus-2-sars-cov-2-and-coronavirus/)
- [Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy](https://scholariq.org/papers/baseline-characteristics-and-outcomes-of-1591-patients-infected-with-sars-cov-2/)
- [A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19](https://scholariq.org/papers/a-trial-of-lopinavir-ritonavir-in-adults-hospitalized-with-severe-covid-19/)
- [Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China](https://scholariq.org/papers/dysregulation-of-immune-response-in-patients-with-coronavirus-2019-covid-19-in/)
- [Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China](https://scholariq.org/papers/cancer-patients-in-sars-cov-2-infection-a-nationwide-analysis-in-china/)
- [Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China](https://scholariq.org/papers/association-of-cardiac-injury-with-mortality-in-hospitalized-patients-with-covid/)
- [Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)](https://scholariq.org/papers/cardiovascular-implications-of-fatal-outcomes-of-patients-with-coronavirus/)
- [Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis](https://scholariq.org/papers/comorbidity-and-its-impact-on-1590-patients-with-covid-19-in-china-a-nationwide/)
- [Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial](https://scholariq.org/papers/remdesivir-in-adults-with-severe-covid-19-a-randomised-double-blind-placebo/)
- [Extrapulmonary manifestations of COVID-19](https://scholariq.org/papers/extrapulmonary-manifestations-of-covid-19/)
- [Kidney disease is associated with in-hospital death of patients with COVID-19](https://scholariq.org/papers/kidney-disease-is-associated-with-in-hospital-death-of-patients-with-covid-19/)
- [In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)](https://scholariq.org/papers/in-vitro-antiviral-activity-and-projection-of-optimized-dosing-design-of/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.